Traws Pharma, Inc. - Common stock, par value $.01 per share (TRAW)
CUSIP: 68232V884
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common stock, par value $.01 per share
- Shares outstanding
- 8,133,373
- Total 13F shares
- 646,356
- Share change
- +636,400
- Total reported value
- $3,800,574
- Price per share
- $5.88
- Number of holders
- 10
- Value change
- +$3,742,033
- Number of buys
- 9
Quarterly Holders Quick Answers
What is CUSIP 68232V884?
CUSIP 68232V884 identifies TRAW - Traws Pharma, Inc. - Common stock, par value $.01 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Newer quarter: Q4 2024
Recent filing periods for CUSIP 68232V884:
Top shareholders of TRAW - Traws Pharma, Inc. - Common stock, par value $.01 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Viriom, Inc. |
3/4/5
|
10%+ Owner |
—
class O/S missing
|
1,645,100
|
$1,480,590 | — | 03 Apr 2024 | |
| ORBIMED ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
1,045,261
|
$466,918 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
—
class O/S missing
|
706,921
|
$315,782 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
248,878
|
$111,174 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
—
class O/S missing
|
224,086
|
$100,115 | — | 30 Jun 2024 | |
| Steven M. Fruchtman |
3/4/5
|
PRESIDENT, CHIEF EXECUTIVE OFF, Director |
—
mixed-class rows
|
121,014
mixed-class rows
|
$98,282 | — | 13 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
218,094
|
$97,423 | — | 30 Jun 2024 | |
| Marex Group plc |
13F
|
Company |
—
class O/S missing
|
148,023
|
$66,122 | — | 30 Jun 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
—
class O/S missing
|
121,011
|
$54,056 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
98,577
|
$44,064 | — | 30 Jun 2024 | |
| Abraham N. Oler |
3/4/5
|
SVP Corp Dev & Gen Counsel |
—
mixed-class rows
|
96,197
mixed-class rows
|
$36,818 | — | 07 Feb 2022 | |
| STATE STREET CORP |
13F
|
Company |
—
class O/S missing
|
60,090
|
$26,842 | — | 30 Jun 2024 | |
| Mark S. Gelder MD |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
mixed-class rows
|
82,667
mixed-class rows
|
$13,847 | — | 13 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
—
class O/S missing
|
30,655
|
$13,694 | — | 30 Jun 2024 | |
| Virtu Financial LLC |
13F
|
Company |
—
class O/S missing
|
27,356
|
$12,000 | — | 30 Jun 2024 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
—
class O/S missing
|
25,062
|
$11,195 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
—
class O/S missing
|
18,255
|
$8,155 | — | 30 Jun 2024 | |
| Ground Swell Capital, LLC |
13F
|
Company |
—
class O/S missing
|
14,047
|
$6,275 | — | 30 Jun 2024 | |
| Beacon Pointe Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
12,714
|
$5,679 | — | 30 Jun 2024 | |
| Mutual Advisors, LLC |
13F
|
Company |
—
class O/S missing
|
12,700
|
$5,460 | — | 30 Jun 2024 | |
| EDMOND DE ROTHSCHILD HOLDING S.A. |
13F
|
Company |
—
class O/S missing
|
6,666
|
$2,978 | — | 30 Jun 2024 | |
| MATHER GROUP, LLC. |
13F
|
Company |
—
class O/S missing
|
2,400
|
$2,424 | — | 30 Jun 2024 | |
| Vermillion & White Wealth Management Group, LLC |
13F
|
Company |
—
class O/S missing
|
5,133
|
$2,293 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
—
class O/S missing
|
3,508
|
$1,568 | — | 30 Jun 2024 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
—
class O/S missing
|
1,613
|
$721 | — | 30 Jun 2024 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
—
class O/S missing
|
306
|
$137 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
—
class O/S missing
|
209
|
$93 | — | 30 Jun 2024 | |
| Pacific Capital Wealth Advisors, Inc. |
13F
|
Company |
—
class O/S missing
|
66
|
$29 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
—
class O/S missing
|
55
|
$25 | — | 30 Jun 2024 | |
| Cornerstone Planning Group LLC |
13F
|
Company |
—
class O/S missing
|
33
|
$12 | — | 30 Jun 2024 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
—
class O/S missing
|
3
|
$1 | — | 30 Jun 2024 | |
| Luba Greenwood |
3/4/5
|
Director |
—
class O/S missing
|
164,000
|
— | — | 16 Sep 2024 | |
| Victor M. Moyo |
3/4/5
|
CHIEF MEDICAL OFFICER |
—
class O/S missing
|
125,000
|
— | — | 02 Oct 2023 | |
| James J. Marino |
3/4/5
|
Director |
—
class O/S missing
|
66,468
|
— | — | 10 Aug 2023 | |
| Jerome Groopman |
3/4/5
|
Director |
—
class O/S missing
|
66,468
|
— | — | 10 Aug 2023 | |
| Peter Atadja |
3/4/5
|
Director |
—
class O/S missing
|
66,468
|
— | — | 10 Aug 2023 | |
| Viren Mehta |
3/4/5
|
Director |
—
class O/S missing
|
66,468
|
— | — | 10 Aug 2023 |
Institutional Holders of Traws Pharma, Inc. - Common stock, par value $.01 per share (TRAW) as of Q3 2024
As of 30 Sep 2024,
Traws Pharma, Inc. - Common stock, par value $.01 per share (TRAW) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
646,356 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, VANGUARD GROUP INC, BlackRock, Inc., BANK OF AMERICA CORP /DE/, MORGAN STANLEY, UBS Group AG, Tower Research Capital LLC (TRC), Vermillion & White Wealth Management Group, LLC, GROUP ONE TRADING LLC, and DANSKE BANK A/S.
This page lists
11
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q4 2025 Across Filers
Q4 2025 holders
21
Q3 2024 holders
10
Holder diff
-11
| Investor | Q4 2025 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.